Clinical trial
An Observational Study Collecting Real-World Data on Intranasal IVIG Treatment in Long COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients With Immunodeficiency Engaged in International Medical Tourism
NCT06992401 is registered in ClinicalTrials.gov with Tamara C Tamas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study Collecting Real-World Data on Intranasal IVIG Treatment in Long COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients With Immunodeficiency Engaged in International Medical Tourism
- Lead sponsor
- Tamara C Tamas
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- August 1, 2026
- Completion date
- July 15, 2029
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
covid 19 associated coagulopathy, covid-19 vaccination, long covid, long covid fatigue, long covid syndrome, post-acute sequelae of sars-cov-2 infection